{
    "code": "56025270",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=56025270",
    "time": "2017-12-22 03:09:09",
    "許可證字號": "衛部醫器輸字第025270號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/08\/26",
    "發證日期": "102\/08\/26",
    "許可證種類": "醫　器",
    "舊證字號": "",
    "醫療器材級數": "第二等級",
    "通關簽審文件編號": "DHA05602527006",
    "中文品名": "立可測 全血免疫抑制品管液",
    "英文品名": "Liquichek Whole Blood Immunosuppressant Control",
    "效能": "本產品為一已分析品管物質，預定用以監控表中分析物：Cyclosporine, Everolimus, Sirolimus, Tacrolimus之實驗室測試步驟的精密度。",
    "醫器規格": "657 (12x2 mL)、659 (6x2 mL)、657X(4x2 mL)\r\n以下空白\r\n增加規格：詳如中文仿單核定本。\r\n註銷規格：657、659、657X，以下空白（原102年9月10日仿單標籤核定本正本收回作廢）。",
    "劑型": "",
    "包裝": "",
    "標籤、仿單及包裝加註": "",
    "": "",
    "醫器主類別一": "A臨床化學及臨床毒理學",
    "醫器次類別一": "A1660品管材料(分析與非分析)",
    "醫器主類別二": "",
    "醫器次類別二": "",
    "醫器主類別三": "",
    "主成分略述": [
        ""
    ],
    "限制項目": "02輸　入",
    "申請商名稱": "0939801100  美商伯瑞股份有限公司台灣分公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "M461707000  BIO-RAD LABORATORIES",
        "製造廠廠址": "9500 JERONIMO ROAD, IRVINE, CA 92618, U.S.A.",
        "製造廠公司地址": "",
        "": ""
    },
    "藥理治療分類": "",
    "ingredients": [],
    "仿單外盒": [
        {
            "title": "560252700001-103-09-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56025270&Seq=002&Type=9"
        },
        {
            "title": "560252700001-102-10-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56025270&Seq=001&Type=9"
        },
        {
            "title": "560252700001-103-09-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56025270&Seq=002&Type=8"
        },
        {
            "title": "560252700002-102-10-03.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=56025270&Seq=001&Type=8"
        }
    ]
}